Aprea Therapeutics, Inc.
APRE
Revenue
0.00
0.000.00%
-Assets
14.32M
▼-2.99M▼-17.26%
3 Months ChangeLiabilities
3.95M
▼-276.57k▼-6.54%
3 Months ChangeFree Cash Flow
-3.94M
▲3.61M▲47.79%
48 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2026-02-18
Form 8-K
ID: 0001104659-26-016797
2026-01-29
Form 8-K
ID: 0001104659-26-007988
2026-01-23
Form 8-K
ID: 0001104659-26-006267
2026-01-09
Form 8-K
ID: 0001104659-26-002490
2025-12-09
Form 8-K
ID: 0001104659-25-119680
2025-11-12
Form 10-Q
ID: 0001104659-25-109867
2025-11-12
Form 8-K
ID: 0001104659-25-109860
2025-10-24
Form 8-K
ID: 0001104659-25-102004
2025-10-15
Form 8-K
ID: 0001104659-25-099534
2025-09-08
Form 8-K
ID: 0001558370-25-011909